Toxic medications in Charcot–Marie–Tooth patients: A systematic review

G Cavaletti, K Forsey, P Alberti - Journal of the Peripheral …, 2023 - Wiley Online Library
Abstract Background and Aims Several widely used medications, with a relevant efficacy
profile, are toxic to the peripheral nervous system and an even larger number of agents are …

Whole genome sequencing increases the diagnostic rate in Charcot-Marie-Tooth disease

CJ Record, M Pipis, M Skorupinska, J Blake, R Poh… - Brain, 2024 - academic.oup.com
Abstract Charcot-Marie-Tooth disease (CMT) is one of the most common and genetically
heterogeneous inherited neurological diseases, with more than 130 disease-causing genes …

Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders

J van Eyll, R Prior, S Celanire… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Inhibition of the enzymatic function of HDAC6 is currently being explored in
clinical trials ranging from peripheral neuropathies to cancers. Advances in selective …

Clinical spectrum and frequency of Charcot–Marie–Tooth disease in Italy: data from the national CMT registry

C Pisciotta, A Bertini, I Tramacere… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Data are reported from the Italian CMT Registry. Methods The
Italian CMT Registry is a dual registry where the patient registers and chooses a reference …

An integrative analysis of genotype-phenotype correlation in Charcot Marie Tooth type 2A disease with MFN2 variants: a case and systematic review

Y Zhang, D Pang, Z Wang, L Ma, Y Chen, L Yang… - Gene, 2023 - Elsevier
Dominant genetic variants in the mitofusin 2 (MFN2) gene lead to Charcot-Marie-Tooth type
2A (CMT2A), a neurodegenerative disease caused by genetic defects that directly damage …

Anesthetic Considerations for Patients with Hereditary Neuropathy with Liability to Pressure Palsies: A Narrative Review

K Laudanski, O Elmadhoun, A Mathew… - Healthcare, 2024 - mdpi.com
Hereditary neuropathy with liability to pressure palsies (HNPP) is an autosomal dominant
demyelinating neuropathy characterized by an increased susceptibility to peripheral nerve …

Early differential diagnosis between acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy in …

Z Yu, Y Xue, H Luo, Y Li, S Hong, M Cheng… - European Journal of …, 2024 - Elsevier
Background To identify clinical factors and biomarkers that could contribute to early
differential diagnosis of acute inflammatory demyelinating polyneuropathy (AIDP) and acute …

[HTML][HTML] Clinical practice guidelines for the diagnosis and management of Charcot-Marie-Tooth disease

RS Mascaró, TG Sobrino, AH Hernández… - Neurología (English …, 2024 - Elsevier
Abstract Introduction Charcot-Marie-Tooth disease (CMT) is classified according to
neurophysiological and histological findings, the inheritance pattern, and the underlying …

Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy

A Bertini, L Gentile, T Cavallaro, S Tozza… - Journal of Neurology …, 2024 - jnnp.bmj.com
Background We aimed to investigate the clinical features of a large cohort of patients with
myelin protein zero (MPZ)-related neuropathy, focusing on the five main mutation clusters …

[HTML][HTML] Population-based incidence rates of 15 neuromuscular disorders: a nationwide capture-recapture study in the Netherlands

JCW Deenen, CGC Horlings, NC Voermans… - Neuromuscular …, 2024 - Elsevier
Most neuromuscular disorders are rare, but as a group they are not. Nevertheless,
epidemiological data of specific neuromuscular disorders are scarce, especially on the …